Tupper Colleen 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

Collegium (COLL) CFO Colleen Tupper Receives RSU/PSU Awards

What Happened

On 2026-02-10, Colleen Tupper, Chief Financial Officer of Collegium Pharmaceutical, was granted 26,421 restricted stock units (RSUs) and had 32,734 performance share units (PSUs) determined to be performance-vested. To satisfy withholding tax obligations on the vested awards, the issuer withheld 11,861 and 26,679 shares (total 38,540 shares) at $46.75 per share, resulting in amounts withheld of $554,502 and $1,247,243 respectively (total ~$1,801,745). The RSUs were granted at $0.00 (no purchase price).

Key Details

Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (appears timely).
Awards: 26,421 RSUs (grant) and 32,734 PSUs (performance-vested) — total 59,155 award units.
Withheld/disposed for taxes: 38,540 shares withheld at $46.75 each, total ~$1.80M (reported as code F — tax withholding).
Shares owned after transaction: Not specified in the filing.
Footnotes: F1 describes RSU vesting schedule (1/3 vests Feb 10, 2027; remainder in equal annual installments over two years). F2 confirms PSUs met performance criteria and vested. F3/F4 note shares were withheld by the issuer to satisfy tax withholding.

Context

This was a compensation/vesting event (awards and performance vesting), not an open-market sale or purchase. The withheld shares reflect the company retaining shares to cover required taxes (a common cashless withholding practice), not an insider-initiated sale.

Form 4

Period: 2026-02-10

EVP & Chief Financial Officer

Transactions

Award
Common Stock
[F1]
2026-02-10+26,421→ 153,088 total
Award
Common Stock
[F2]
2026-02-10+32,734→ 185,822 total
Tax Payment
Common Stock
[F3]
2026-02-10$46.75/sh−11,861$554,502→ 173,961 total
Tax Payment
Common Stock
[F4]
2026-02-10$46.75/sh−26,679$1,247,243→ 147,282 total

Footnotes (4)

[F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
[F2]Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,734 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
[F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
[F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Signature

/s/ Colleen Tupper|2026-02-12

1 file